Molecular model of cyclin-dependent kinase 5 complexed with roscovitine

被引：69

作者：

de Azevedo, WF ^{[1
]}

Gaspar, RT

Canduri, F

Camera, JC

da Silveira, NJF

机构：

[1] UNESP, IBILCE, Dept Fis, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil

[2] Inst Butantan, Ctr Appl Toxinol, BR-05503900 Sao Paulo, Brazil

来源：

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2002年 / 297卷 / 05期

基金：

巴西圣保罗研究基金会;

关键词：

CDK; roscovitine; bioinformatics; structure; drug design;

D O I：

10.1016/S0006-291X(02)02352-5

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Here is described a structural model for the binary complex CDK5-roscovitine. Roscovitine has been shown to potently inhibit cyclin-dependent kinases 1, 2 and 5 (CDK1, 2, and 5), and the structure of CDK2 complexed with roscovitine has been reported; however, no structural data, are available for complexes of CDK5 with inhibitors. The structural model indicates that roscovitine strongly binds to the ATP-binding pocket of CDK5 and structural comparison of the CDK2-roscovitine complex correlates the structural differences with differences in inhibition of these CDKs by this inhibitor. This structure opens the possibility of testing new inhibitor families, in addition to new substituents for the already known lead structures of adenine derivatives. (C) 2002 Elsevier Science (USA). All rights reserved.

引用

页码：1154 / 1158

页数：5

共 26 条

[1] Inhibition of tau phosphorylating protein kinase cdk5 prevents β-amyloid-induced neuronal death [J].

Alvarez, A ;

Toro, R ;

Cáceres, A ;

Maccioni, RB .

FEBS LETTERS, 1999, 459 (03) :421-426

[2] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].

BAILEY, S .

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763

[3] CALCULATION OF PROTEIN CONFORMATIONS BY PROTON PROTON DISTANCE CONSTRAINTS - A NEW EFFICIENT ALGORITHM [J].

BRAUN, W ;

GO, N .

JOURNAL OF MOLECULAR BIOLOGY, 1985, 186 (03) :611-626

[4] CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS [J].

BROOKS, BR ;

BRUCCOLERI, RE ;

OLAFSON, BD ;

STATES, DJ ;

SWAMINATHAN, S ;

KARPLUS, M .

JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) :187-217

[5] Structure of human uropepsin at 2.45 Å resolution [J].

Canduri, F ;

Teodoro, LGVL ;

Fadel, V ;

Lorenzi, CCB ;

Hial, V ;

Gomes, RAS ;

Neto, JR ;

de Azevedo, WF .

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2001, 57 :1560-1570

[6] Flavopiridol inhibits P-TEFb and blocks HIV-1 replication [J].

Chao, SH ;

Fujinaga, K ;

Marion, JE ;

Taube, R ;

Sausville, EA ;

Senderowicz, AM ;

Peterlin, BM ;

Price, DH .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :28345-28348

[7] The cyclin-dependent kinases cdk2 and cdk5 act by a random, anticooperative kinetic mechanism [J].

Clare, PM ;

Poorman, RA ;

Kelley, LC ;

Watenpaugh, KD ;

Bannow, CA ;

Leach, KL .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (51) :48292-48299

[8]

de Azevedo WF, 2002, BIOCHEM BIOPH RES CO, V293, P566

[9] Molecular model for the binary complex of uropepsin and pepstatin [J].

de Azevedo, WF ;

Canduri, F ;

Fadel, V ;

Teodoro, LGVL ;

Hial, V ;

Gomes, RAS .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 287 (01) :277-281

[10] Inhibition of cyclin-dependent kinases by purine analogues - Crystal structure of human cdk2 complexed with roscovitine [J].

DeAzevedo, WF ;

Leclerc, S ;

Meijer, L ;

Havlicek, L ;

Strnad, M ;

Kim, SH .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2) :518-526

← 1 2 3 →